PanTera signs supply agreement with Bayer for actinium-225

PanTera has signed an agreement with Bayer for the supply of actinium-225 starting in the second half of 2024.

PanTera is the Belgian joint venture created by Ion Beam Applications (IBA) and SCK CEN to secure large-scale production of alpha-emitting radioisotopes.

The agreement with Bayer is the first agreement with a major drug developer, PanTera said. The company plans to work on increasing access to actinium-225 for clinical trials, as well as on the development of a large-scale production facility to address growing global demand.

Page 1 of 1